influenza
reappear
everi
season
caus
circul
influenza
type
type
b
virus
virus
evolv
genet
mutat
result
antigen
chang
allow
evad
host
immun
influenza
vaccin
updat
period
order
effect
follow
season
henc
constant
need
season
vaccin
take
approxim
month
produc
influenza
vaccin
recommend
need
done
advanc
world
health
organ
conven
annual
meet
februari
septemb
year
establish
composit
influenza
vaccin
forthcom
season
northern
southern
hemispher
respect
chamber
et
al
webster
et
al
season
influenza
virus
predomin
among
circul
influenza
virus
consequ
viru
recommend
vaccin
compon
februari
new
group
virus
detect
late
march
vaccin
manufactur
begun
led
antigen
mismatch
circul
virus
virus
includ
vaccin
season
ecdc
epidem
season
clinic
specimen
test
poland
addit
select
specimen
voivodship
sanitari
epidemiolog
station
vse
test
nation
influenza
center
nation
institut
public
health
nation
institut
hygien
refer
laboratori
poland
verifi
result
obtain
station
specimen
test
consist
mainli
nasal
throat
swab
patient
categor
seven
agegroup
year
old
viral
rna
extract
use
maxwel
viral
total
nucleic
acid
purif
kit
promega
corpor
madison
wi
clinic
sampl
viral
transport
medium
pb
accord
manufactur
instruct
low
elut
volum
lev
cartridg
rna
elut
rnasefre
water
rna
viru
sampl
type
vse
thu
subtyp
influenza
virus
achiev
detect
subtyp
perform
onestep
realtim
rtpcr
reaction
perform
use
roch
light
cycler
system
roch
diagnost
rotkreuz
switzerland
rtpcr
reaction
perform
capillari
tube
volum
nm
primer
nm
probe
reaction
primer
probe
obtain
influenza
reagent
resourc
irr
program
american
center
diseas
prevent
control
reaction
mixtur
contain
reaction
buffer
buffer
bsa
rnasefre
taq
mix
invitrogen
life
technolog
thermo
fisher
scientif
carlsband
ca
incub
rna
sampl
per
capillari
tube
rna
vaccin
virus
introduc
posit
control
rnasefre
util
neg
control
sampl
dna
amplif
cycl
begun
rna
templat
revers
transcrib
produc
correspond
cdna
templat
revers
transcript
procedur
min
dna
templat
subject
initi
step
cycl
min
follow
cycl
amplif
denatur
anneal
elong
fifti
five
specimen
patient
store
test
rtpcr
use
ace
detect
kit
seegen
seoul
south
korea
detect
follow
respiratori
virus
influenza
b
virus
human
respiratori
syncyti
viru
human
respiratori
syncyti
viru
b
human
adenoviru
human
metapneumoviru
human
coronaviru
human
coronaviru
human
parainfluenza
viru
human
parainfluenza
viru
human
parainfluenza
viru
human
rhinoviru
ab
random
cdna
synthesi
product
gener
use
first
strand
cdna
synthesi
kit
fermenta
york
uk
accord
manufactur
instruct
store
use
cdna
prepar
subject
pcr
procedur
accord
manufactur
instruct
seegen
seoul
south
korea
afterward
amplicon
detect
gel
electrophoresi
influenza
epidem
season
poland
start
week
januari
februari
continu
week
april
influenza
activ
moder
highest
incid
influenzalik
ill
ili
week
march
fig
season
specimen
test
influenza
influenzalik
virus
n
posit
influenza
detail
n
influenza
type
b
influenza
n
influenza
n
nonsubtyp
influenza
type
observ
cocircul
influenza
type
b
virus
influenza
preval
one
fig
infect
caus
influenzalik
virus
account
n
test
specimen
respiratori
syncyti
viru
rsv
predomin
viru
constitut
n
ili
case
follow
sporad
case
human
coronaviru
n
parainfluenza
n
rhinoviru
n
adenoviru
n
parainfluenza
virus
n
fig
highest
percentag
influenza
ili
confirm
case
note
year
agegroup
follow
year
year
agegroup
lowest
morbid
observ
year
year
agegroup
fig
verif
specimen
test
vse
demonstr
complet
agreement
result
obtain
nation
influenza
center
tabl
epidem
season
poland
number
specimen
receiv
primari
care
physician
similar
although
percentag
influenza
influenzalik
infect
confirm
higher
latter
season
morbid
children
age
year
twice
much
former
epidem
season
vast
major
infect
group
children
induc
influenzalik
virus
season
case
influenzalik
virus
predomin
viru
rsv
infect
caus
respiratori
virus
occur
sporad
influenza
case
caus
mainli
influenza
type
proport
influenza
b
significantli
higher
season
previou
season
amount
influenza
confirm
bednarska
et
al
compar
data
poland
europ
appar
proport
circul
virus
influenza
type
b
remain
similar
europ
whole
world
alik
domin
strain
cocircul
influenza
predomin
strain
also
note
poland
even
take
account
fact
specimen
test
within
sentinel
nonsentinel
influenza
surveil
subtyp
broberg
et
al
ecdcwho
mccauley
et
al
rolf
et
al
season
antigen
drift
subtyp
decreas
effect
vaccin
influenza
yet
vaccin
remain
effect
cheapest
method
influenza
prevent
broberg
et
al
sinc
advisori
committe
immun
practic
acip
recommend
trival
vaccin
influenza
contain
two
subtyp
influenza
viru
one
lineag
influenza
viru
type
b
emphas
peopl
particularli
receiv
vaccin
everi
season
substanti
enhanc
immunolog
memori
